An estimated 1 in 7 GLP-1 users has already tried microdosing.* * Based on a 2026 survey of 8,000+ GLP-1 users
Clinical efficacy : Large randomised controlled trials demonstrate that GLP-1 receptor agonists can reduce HbA1c by approximately 1.01.5% and produce weight loss of 515% of body weight, with the higher end of weight loss typically seen with higher-dose semaglutide (2.4mg/Wegovy) specifically for obesity treatment
Combination treatment was well-tolerated and led to improved pain relief in patients with suboptimal pain control with a monotherapy [65]
Our mission is to provide you with the best tools, in the most effective formats, so you can focus on what you do best: pushing the boundaries of science
While your provider will give you specific instructions, many patients find it helpful to check their blood pressure at least once or twice a week when starting a new medication
This holistic approach to medical weight management helps to ensure that patients not only lose weight but also develop sustainable habits that support ongoing health and well-being
